Search
for
Sort by
Research 271–300 of 1000+
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Non-viral delivery of the CRISPR/Cas system: DNA<i>versus</i>RNA<i>versus</i>RNP
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development
- Health improvement of human hair and their reshaping using recombinant keratin K31
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Recent Advances in the Medical and Surgical Treatment of Priapism
- Combinatorial expression of cell cycle regulators is more suitable for immortalization than oncogenic methods in dermal papilla cells
- MiR-23b and miR-133 Cotarget TGFβ2/NOTCH1 in Sheep Dermal Fibroblasts, Affecting Hair Follicle Development
- Types of Human Stem Cells and Their Therapeutic Applications
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Drug-induced scarring and permanent alopecia
- Tissue expansion techniques in reconstructive surgery: a 10-year bibliometric analysis
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Drug-induced hair pigmentation: Clinical perspectives and updates
- LHX2: a transcription factor in development, homeostasis, repair, and disease
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Xiaozhi Yufa decoction ameliorates androgenetic alopecia through inhibition of MAPK signaling and regulation of lipid metabolism
- Signal integrator function of CXXC5 in Cancer
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
- TRANSMEDCON 2022: E-Poster Abstracts
- New frontiers in CRISPR/Cas9 delivery systems delivery for gene editing